Authors of a comprehensive review of literature reporting data on per-act HIV transmission risks have updated the last estimates produced by the U.S. Centers for Disease Control and Prevention in 2005, and in the process have highlighted the importance of treatment and prevention reaching those at greatest risk. The CDC’s estimates “relied heavily on estimates […]
Science Speaks is in Atlanta, Georgia this week and will be live-blogging from the 20th CROI — Conference on Retroviruses and Opportunistic Infections from Sunday to Wednesday, covering breaking developments from investigators on cure research, new antiretroviral agents, hepatitis, tuberculosis and treatment as prevention. Perhaps at some point what the VOICE trial (Vaginal and Oral […]
Dr. Rochelle Walensky has been a member of the Cost-effectiveness of Preventing AIDS Complications (CEPAC) team since 1998. She is a member of the Office of AIDS Research Advisory Council at the National Institutes of Health and the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Dr. Walensky has […]
There is a pervasive pattern of stockouts of condoms, both male and female condoms, in African countries confronting HIV/AIDS, according to Carolyn Ryan, MD, MPH, director of technical leadership at the Office of the Global AIDS Coordinator (OGAC).
She called the condom gap “really quite disturbing,” given that condoms are a crucial tool for HIV prevention. While HIV incidence has fallen in recent years, in 2009 there were an estimated 2.6 million people newly infected with HIV, meaning that about 7000 people are acquiring the infection each day.